Inactive Instrument

Celltrion Healthcare Co., Ltd. Stock price

Equities

A091990

KR7091990002

Pharmaceuticals

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 62 -
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 16-03-28
Chairman 66 -
Chief Executive Officer 62 -
More insiders
Celltrion Healthcare Co Ltd is a Korea-based company principally engaged in the marketing and distribution of biopharmaceuticals. The Company provides Remsima, an infliximab biosimilar used for the treatment of rheumatoid arthritis, ankylosing spondylitis, adult and child crohn's disease, psoriasis, psoriatic arthritis and ulcerative colitis. It also offers Truxima, a rituximab biosimilar used for the treatment of non-Hodgkin lymphomas, chronic lymphocytic leukemia and rheumatoid arthritis. The Company distributes its products in domestic and overseas markets.
More about the company
  1. Stock
  2. Equities
  3. Stock Celltrion Healthcare Co., Ltd. - Korea S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer